Measurement of novel adipokine visfatin in young patients with acute myocardial infarction. Clinical testing of a new ELISA
Objectives: Adipose tissue produces a number of adipokines that have metabolic effect. Visfatin is a recently discovered adipokine whose concentration in plasma increases in obesity. It is also a proinflammatory mediator that promotes atherosclerosis and plays a role in plaque destabilization. The a...
Main Authors: | David Stejskal, Radka Sigutova, Marek Svestak, Jan Vaclavik, Pavlina Kusnierova, Zdenek Svagera |
---|---|
Format: | Article |
Language: | English |
Published: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2020-06-01
|
Series: | Biomedical Papers |
Subjects: | |
Online Access: | https://biomed.papers.upol.cz/artkey/bio-202002-0003_measurement-of-novel-adipokine-visfatin-in-young-patients-with-acute-myocardial-infarction-clinical-testing-of.php |
Similar Items
-
Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01) -
Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication
by: David Stejskal, et al.
Published: (2016-06-01) -
Salivary visfatin concentrations in patients with chronic periodontitis: An analysis before and after periodontal therapy
by: Anudeep Mopidevi, et al.
Published: (2019-01-01) -
Adipokines and cardiovascular disease: A comprehensive review
by: Ales Smekal, et al.
Published: (2017-03-01) -
RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-04-01)